πŸ‡ΊπŸ‡Έ FDA
Patent

US 11446342

Composite probiotics and use thereof

granted A61KA61K35/745A61K35/747

Quick answer

US patent 11446342 (Composite probiotics and use thereof) held by INFINITUS (CHINA) COMPANY LTD. expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INFINITUS (CHINA) COMPANY LTD.
Grant date
Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K35/745, A61K35/747, A61K47/26, A61K9/0095